Here is Why ONEOK (OKE) is Among the Best Oil and Gas Dividend Stocks to Buy Now
Known for its stable cash flows backed by government-regulated rate structures and long-term contracts, ONEOK, Inc.
Insider Monkey Blog
Here is Why Civitas Resources (CIVI) is a Great Addition to Your Dividend Portfolio
To make sure it keeps its shareholders happy, Civitas Resources, Inc.
BP p.l.c. (BP) – A Good Option for Dividend Investors
BP p.l.c. (NYSE:BP) raised its dividend by 4% to $0.0832 per share in August, in addition to announcing a $750 million share buyback for the second quarter.
Phillips 66 (PSX) – Among the Best Natural Gas and Oil Dividend Stocks to Invest in
Known for its high and consistent shareholder returns, Phillips 66 (NYSE:PSX) has increased its dividend at an 11.7% CAGR since 2013 through the end of 2024.
Permian Resources Corporation (PR) – A Top Dividend Stock Among Hedge Funds
Thanks to its industry-leading cost structure and low break-evens, Permian Resources Corporation (NYSE:PR) is able to generate strong cash flows and deliver high shareholder returns...
Here is Why Chord Energy (CHRD) Makes for a Great Dividend Stock
Chord Energy Corporation (NASDAQ:CHRD) presents an attractive investment opportunity due to its strong balance sheet, consistent free cash flow, and significant shareholder ...
Kinder Morgan (KMI) – A Great Dividend Stock Amongst the LNG Boom
Kinder Morgan, Inc. (NYSE:KMI), a company that paid dividends of $1.3 billion in the first half of 2025.
Is Schlumberger (SLB) a Good Dividend Stock to Buy Now?
Schlumberger Limited (NYSE:SLB) completed the acquisition of ChampionX Corporation in July, bringing in the latter’s $850 million in revenue and $190 million in adjusted EBITDA...
Why ConocoPhillips (COP) is Among the Top Oil and Gas Dividend Stocks
With its deep, diverse, and durable portfolio, ConocoPhillips (NYSE:COP) boasts a breakeven level of less than $40 a barrel, putting the company at an advantage to navigate sector...
Chevron Corporation (CVX) – A Great Option for Your Dividend Stock Portfolio
Chevron Corporation (NYSE:CVX) made headlines this year when it completed the acquisition of Hess, adding its coveted 30% stake in the Stabroek Block in offshore Guyana to the...
Why Exxon Mobil (XOM) is a Top Dividend Stock to Buy Now
A behemoth of the global oil and gas industry, Exxon Mobil Corporation (NYSE:XOM) has increased its earnings at an annual rate of roughly 30% over the last five years, with its...
Market in Pain? Not For These 10 Celebrating Stocks
Ten stocks boasted a strong performance amid a lackluster market on Tuesday, with four soaring to new all-time highs, as investors placed bets after a series of industry-specific...
10 Best Debt Free Small Cap Stocks to Buy Now
High leverage can be both an advantage and a liability.
11 Best Retirement Stocks to Buy According to Analysts
Amid the ongoing small-cap rally, mounting retirement concerns are looming in the U.S.
11 Best Nuclear Energy Stocks to Invest in Right Now
Last month, President Trump signed an executive order to slash red tape and quadruple the nation's nuclear capacity, which significantly boosted the US nuclear energy industry...
15 Best Natural Gas and Oil Dividend Stocks to Buy Now
Dividend stocks make for an essential long-term component of any portfolio, since dividend-paying stocks have historically performed better during market downturns.
Johnson & Johnson Impresses with Earnings Beat, Dividend Hike, and Bullish Analyst Target
Johnson & Johnson (NYSE: JNJ) reported an EPS of $2.77 for the second quarter of 2025 on July 16, 2025, successfully surpassing the consensus analyst estimate of $2.68.
Texas Instruments Delivers Dividend Boost Amid Strong Quarter and Confident Analyst Outlook
On July 22, 2025, Texas Instruments Incorporated (NASDAQ:TXN) reported its Q2 2025 financial results, which included revenue of $4.45 billion. The Diluted EPS stood at $1.41.
Mondelez International Posts Solid Results, Raises Dividend, and Expands Product Line
In its Q2 2025 results, announced on July 29, 2025, Mondelez International, Inc. (NASDAQ:MDLZ) reported an Adjusted EPS of $0.73, beating the consensus estimate of $0.68.
Schlumberger Beats Q2 Estimates Raises Dividend and Completes ChampionX Acquisition
The company reported its Q2 2025 earnings results on July 18, 2025. Its EPS of $0.74 during the quarter beat the consensus estimate of $0.73.
ConocoPhillips Sells Anadarko Assets While Cutting Debt and Maintaining Strong Dividend
ConocoPhillips (NYSE:COP) reported its Q2 2025 results on August 7, 2025, which highlighted an operational performance despite a decline in earnings from the previous year.
Keurig Dr Pepper Moves to Acquire JDE Peet’s While Planning Company Split and Sustaining Dividend
The Q2 2025 earnings results reported on July 24, 2025, indicated that the company had met analyst consensus estimates with an Adjusted EPS of $0.49.
Exxon Mobil Boosts Q2 Performance While Acquiring Superior Graphite and Strengthening Dividend
On August 1, 2025, Exxon Mobil Corporation (NYSE:XOM) reported Q2 2025 earnings of $7.1 billion.
Coterra Energy Reports Strong Q2 Growth Despite Lowered Price Targets and Boosts Dividend Appeal
The company’s Q2 2025 earnings results were released on August 4, 2025, highlighting a revenue of $1.97 billion, which significantly surpassed the consensus estimate of $1.73...
Phillips 66 Expands Refining Capacity and Strengthens Dividend Outlook Following Q2 Beat
On July 25, 2025, Phillips 66 (NYSE:PSX) reported a strong Q2 2025, with Adjusted EPS of $2.38 and revenues of $33.5 billion, both beating the analyst consensus estimates.
Merck Gains FDA Approval for KEYTRUDA QLEX and Supports Dividend Appeal
Merck & Co., Inc. (NYSE:MRK) reported an Adjusted EPS of $2.13 for the second quarter of 2025.
Chevron Advances with Hess Acquisition and Divestiture Plans While Maintaining Dividend Appeal
On August 1, 2025, Chevron Corporation (NYSE:CVX) reported Q2 2025 earnings of $2.5 billion, a huge drop from the prior year’s Q2 revenue of $4.4 billion.
Pfizer Raises EPS Guidance and Expands Cost-Cutting Plan While Boosting Dividend Appeal
Pfizer Inc. (NYSE:PFE)’s second-quarter results were reported on August 5, 2025, where it highlighted a year-over-year increase in revenue of 10%, reaching $14.7 billion.
Entero Therapeutics, Inc. (ENTO) Names Jason D. Sawyer as New CEO Amid Strategic Shift
Entero Therapeutics, Inc.
Relmada Therapeutics, Inc. (RLMD) Advances Oncology and CNS Therapies with Promising Phase 2 Data
Relmada Therapeutics, Inc. (NASDAQ:RLMD) is a clinical-stage biotech company that develops innovative therapies for oncology and central nervous system disorders.
Tiziana Life Sciences Ltd (TLSA) Secures U.S. DoD Grant to Advance Intranasal Foralumab for Spinal Cord Injury
Tiziana Life Sciences Ltd (NASDAQ:TLSA) is a clinical-stage biotech company focused on next-generation immunomodulation therapies for neuroinflammatory and neurodegenerative diseases...
NovaBay Pharmaceuticals, Inc. (NBY) Declares $0.80 Special Dividend, Boosting Shareholder Value
NovaBay Pharmaceuticals, Inc. (NYSE:NBY) is a biopharmaceutical company specializing in anti-infective therapies for inflammation and infection-related conditions.
Lineage Cell Therapeutics, Inc. (LCTX) Shows Vision Gains in Phase 1/2a OpRegen Trial
Lineage Cell Therapeutics, Inc.
Precigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS Commercialization
Precigen, Inc. (NASDAQ:PGEN) is a biotechnology company developing precision genetic medicines for oncology, infectious diseases, and rare conditions.
Matinas BioPharma Holdings, Inc. (MTNB) Restructures Amid Challenges, Focuses on Oral Antifungal MAT2203
Matinas BioPharma Holdings, Inc.
Galectin Therapeutics Inc. (GALT) Surges on Promising Belapectin Trial Data and Strong Financials
Galectin Therapeutics Inc.
I-Mab (IMAB) Shows 83% Response Rate for Givastomig in Metastatic Gastric Cancer
I-Mab (NASDAQ:IMAB) is a U.S.-based biotechnology company focused on precision immuno-oncology, developing differentiated therapies for cancer.
ABVC BioPharma, Inc. (ABVC) Reports 103% Asset Surge, Eyeing Phase III Trials for Depression Therapies
ABVC BioPharma, Inc. (NASDAQ:ABVC) tops our list for being one of the best penny stocks.
Jazz Pharmaceuticals plc (JAZZ) Advances Rare Cancer Portfolio with First CNS Glioma Therapy Approval
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) continues to advance its mission to transform patient lives through innovative therapies for conditions with limited treatment options.
Elanco Animal Health Incorporated (ELAN) Joins S&P MidCap 400 Following Strong Q2 Growth and Product Ramp-Up
Elanco Animal Health Incorporated (NYSE:ELAN), a global leader in veterinary pharmaceuticals and biologics, continues to advance its mission of improving animal health and food...
Royalty Pharma plc (RPRX) Completes $2B Senior Notes Offering, Strengthens Capital for Growth
Royalty Pharma plc (NASDAQ:RPRX), a leader in biopharma royalties, made major strategic moves in September 2025.
Pfizer Inc. (PFE) Targets $4.5B in Cost Savings to Fuel R&D and Innovative Therapies
In September 2025, PFE and BioNTech reported positive Phase 3 data for the LP.8.1-adapted COMIRNATY 2025-2026 COVID-19 vaccine.
Hedge Fund Resource Center
